CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

NCT02030210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2022-04-04

No results posted yet for this study

Summary

RAND/UCLA modified Delphi study on quality indicators for STEMI to determine the appropriateness of quality indicators retrieved from literature and guideline review. We aim to engage 20 cardiologists and 20 nurses with relevant experience in the care for STEMI patients.

Conditions

  • STEMI
  • Quality Indicators

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER
  • KU Leuven

    collaborator OTHER
  • European Pathway Association

    lead OTHER

Principal Investigators

  • Kris Vanhaecht, dr · KU Leuven

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030210 on ClinicalTrials.gov